{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:21:31Z","timestamp":1791814891050,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jaip.2016.12.032","type":"journal-article","created":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T21:50:00Z","timestamp":1489009800000},"page":"1307-1313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency"],"prefix":"10.1016","volume":"5","author":[{"given":"Andrea","family":"Zanichelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia Maria","family":"Azin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena Alessandra","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Suffritti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Caccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Perego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romualdo","family":"Vacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cicardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2016.12.032_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0090-1229(72)90006-2","article-title":"Acquired C1 inhibitor deficiency in lymphosarcoma","volume":"1","author":"Caldwell","year":"1972","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaip.2016.12.032_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1710-1492-6-14","article-title":"Acquired angioedema","volume":"6","author":"Cicardi","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2016.12.032_bib3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0091-6749(86)80111-7","article-title":"The metabolism of C1 inhibitor and C1q in patients with acquired C1-inhibitor deficiency","volume":"77","author":"Melamed","year":"1986","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.12.032_bib4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.iac.2006.08.002","article-title":"Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management","volume":"26","author":"Zingale","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2016.12.032_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2249.1996.d01-866.x","article-title":"Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema","volume":"106","author":"Cicardi","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2016.12.032_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/323722a0","article-title":"An IgG autoantibody which inactivates C1-inhibitor","volume":"323","author":"Jackson","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2016.12.032_bib7","first-page":"523","article-title":"Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen: reversal of complement abnormalities after splenectomy","volume":"37","author":"Hauptmann","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2016.12.032_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V48.4.567.567","article-title":"Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality","volume":"48","author":"Schreiber","year":"1976","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2016.12.032_bib9","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1172\/JCI114084","article-title":"Acquired C1 inhibitor (C1-INH) deficiency type II: replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies","volume":"83","author":"Alsenz","year":"1989","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2016.12.032_bib10","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0091-6749(88)90891-3","article-title":"Acquired angioedema: observations on the mechanism of action of autoantibodies directed against C1 esterase inhibitor","volume":"81","author":"Malbran","year":"1988","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.12.032_bib11","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","article-title":"Plasma bradykinin in angio-oedema","volume":"351","author":"Nussberger","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2016.12.032_bib12","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.12380","article-title":"HAWK under the patronage of EAACI (European Academy of Allergy and Clinical Immunology). Classification, diagnosis and approach to treatment for angioedema: consensus report from HAWK","volume":"69","author":"Cicardi","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.12.032_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13023-015-0233-x","article-title":"A\u00a0nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy","volume":"10","author":"Zanichelli","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaip.2016.12.032_bib14","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM198705283162202","article-title":"Autoantibody-mediated acquired deficiency of C1 inhibitor","volume":"316","author":"Alsenz","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2016.12.032_bib15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/bjh.13908","article-title":"High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency","volume":"172","author":"Castelli","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2016.12.032_bib16","doi-asserted-by":"crossref","first-page":"e4363","DOI":"10.1097\/MD.0000000000004363","article-title":"A\u00a0nationwide study of acquired C1-inhibitor deficiency in France: characteristics and treatment responses in 92 patients","volume":"95","author":"Gobert","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2016.12.032_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1710-1492-9-29","article-title":"Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe","volume":"9","author":"Zanichelli","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2016.12.032_bib18","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1097\/HJH.0b013e32834b4b9b","article-title":"Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema","volume":"29","author":"Beltrami","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jaip.2016.12.032_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/cei.12159","article-title":"A\u00a0UK national audit of hereditary and acquired angioedema","volume":"175","author":"Jolles","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2016.12.032_bib20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1398-9995.2007.01577.x","article-title":"Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema","volume":"63","author":"Bork","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.12.032_bib21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jaci.2012.05.055","article-title":"Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency","volume":"130","author":"Bork","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.12.032_bib22","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archinte.161.5.714","article-title":"Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema","volume":"161","author":"Bork","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2016.12.032_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","article-title":"Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients","volume":"71","author":"Agostoni","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2016.12.032_bib24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0091-6749(89)90082-1","article-title":"Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency","volume":"83","author":"Bork","year":"1989","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.12.032_bib25","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2009.07.017","article-title":"Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks","volume":"124","author":"Craig","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.12.032_bib26","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJM197612232952602","article-title":"Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities","volume":"295","author":"Gelfand","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2016.12.032_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0165-2478(03)00029-4","article-title":"Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol","volume":"86","author":"Pappalardo","year":"2003","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaip.2016.12.032_bib28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa0905079","article-title":"Ecallantide for the treatment of acute attacks in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2016.12.032_bib29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2500\/aap.2013.34.3620","article-title":"Ecallantide for treatment of acute attacks of acquired C1 esterase inhibitor deficiency","volume":"34","author":"Patel","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2016.12.032_bib30","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.12380","article-title":"Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group","volume":"69","author":"Cicardi","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.12.032_bib31","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jaci.2006.01.002","article-title":"Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency","volume":"117","author":"Levi","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.12.032_bib32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM197204132861503","article-title":"Epsilon aminocaproic acid therapy of hereditary angioneurotic edema: a double-blind study","volume":"286","author":"Frank","year":"1972","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2016.12.032_bib33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJM197208312870907","article-title":"Tranexamic acid therapy in hereditary angioneurotic edema","volume":"287","author":"Sheffer","year":"1972","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2016.12.032_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1398-9995.2010.02433.x","article-title":"Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patients","volume":"66","author":"Zanichelli","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.12.032_bib35","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0091-6749(94)90380-8","article-title":"Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid","volume":"93","author":"Cugno","year":"1994","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.12.032_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1034\/j.1600-0609.2002.01607.x","article-title":"Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia","volume":"68","author":"Taparia","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaip.2016.12.032_bib37","first-page":"516","article-title":"Prophylactic use of tranexamic acid and incidence of arterial thrombosis in liver transplantation","volume":"93","author":"Dalmau","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaip.2016.12.032_bib38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1055\/s-0037-1616122","article-title":"No increased risk of venous thrombosis in women taking tranexamic acid","volume":"86","author":"Berntorp","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaip.2016.12.032_bib39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0038-1649475","article-title":"Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications","volume":"70","author":"Lindoff","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaip.2016.12.032_bib40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1742-1241.1989.tb08809.x","article-title":"Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy","volume":"43","author":"Woo","year":"1989","journal-title":"Br J Clin Pract"},{"key":"10.1016\/j.jaip.2016.12.032_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2393-9-29","article-title":"Anti-fibrinolytic agents in post partum haemorrhage: a systematic review","volume":"9","author":"Ferrer","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jaip.2016.12.032_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4103\/0972-5229.118443","article-title":"Acute arterial thrombosis associated with inadvertent high dose of tranexamic acid","volume":"17","author":"Upadhyay","year":"2013","journal-title":"Indian J Crit Care Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817300211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817300211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:13:53Z","timestamp":1761974033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817300211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2213219817300211"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2016.12.032","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2016.12.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}